Portal de Periódicos da CAPES

Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease

2005; Elsevier BV; Volume: 237; Issue: 1 Linguagem: Inglês

10.1016/j.cellimm.2005.10.002

1090-2163

Eric R. Secor, William F. Carson, Michelle M. Cloutier, Linda Guernsey, Craig M. Schramm, Carol A. Wu, Roger S. Thrall,

Pineapple and bromelain studies

Bromelain, a clinically used pineapple extract and natural product, has reported anti-inflammatory and immunomodulatory activities. The purpose of this study was to determine the effect of bromelain treatment in an ovalbumin (OVA)-induced murine model of allergic airway disease (AAD). To establish AAD, mice were sensitized with intraperitoneal (i.p.) OVA/alum and challenged with daily OVA aerosols. Mice were treated i.p. with either saline, 2 or 6 mg/kg bromelain, twice daily for four consecutive days. Bronchoalveolar lavage leukocytes and cytokines, lung histology, airway hyperresponsiveness, and lymphocyte populations via flow cytometry were compared between groups. Bromelain treatment of AAD mice resulted in reduced total BAL leukocytes, eosinophils, CD4+ and CD8+ T lymphocytes, CD4+/CD8+ T cell ratio, and IL-13. Bromelain attenuated development of AAD while altering CD4+ to CD8+ T lymphocyte populations. The reduction in AAD outcomes suggests that bromelain may have similar effects in the treatment of human asthma and hypersensitivity disorders.